| Serial Number | 99035155 |
| Word Mark | FRANKLIN BIO |
| Filing Date | Monday, February 10, 2025 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Monday, October 20, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Custom manufacturing services for others in the fields of viral-based and non-viral vectors, pharmaceuticals, biologics, vaccines, biotechnological medical products, and gene and cell therapy preparations |
| NOT AVAILABLE | BIO |
| Goods and Services | Pharmaceutical research services; Pharmaceutical drug development and discovery services, namely, providing translational research tools and services, namely, providing scientific research in the field of screening, testing, sequencing, and analysis of DNA- and RNA-encoded genetic material for drug candidate development; cell and gene therapy product development services; Analytical services being scientific research services in the field of drug substance and drug product characterization which are for research use and in accordance with Good Manufacturing Practices (GMP); Preclinical services including pharmacology, pharmacokinetics, and toxicology in well established lab animal models; Scientific research and development and Good Laboratory Practices (GLP) services for bioanalytical testing including immunogenicity, biodistribution and shedding to support pre-clinical (animal) and clinical (human) studies; Chemistry, Manufacturing, and Controls (CMC) laboratory and stability testing for quality control purposes and analytical scientific advisory services in the fields of therapeutic drug evaluation and development, bioanalytical testing, immunogenicity testing, clinical studies, pre-clinical studies pharmacology, pharmacokinetics, and toxicology; Good Manufacturing Practices (GMP) laboratory and stability testing for quality control purposes and analytical scientific advisory services in the fields of therapeutic drug evaluation and development, bioanalytical testing, immunogenicity testing, clinical studies, pre-clinical studies pharmacology, pharmacokinetics, and toxicology; Providing laboratory research services for others in accordance with the Clinical Laboratory Improvement Amendments (CLIA) program to support the development of gene and cell therapy, biologics, vaccines, pharmaceuticals, and related biotechnological products; Research and development relating to production and analysis of viral-based vectors, pharmaceuticals, biologics, vaccines, biotechnological products, and gene and cell therapy preparations for use in medical research for others |
| Pseudo Mark | FRANKLIN BIO WORDMARK WITHOUT CLAIM TO FONT STYLE COLOR OR SIZE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, October 20, 2025 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, February 10, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Franklin Biolabs, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | King of Prussia, PA 19406 |
| Event Date | Event Description |
| Monday, February 10, 2025 | NEW APPLICATION ENTERED |
| Monday, February 10, 2025 | APPLICATION FILING RECEIPT MAILED |
| Thursday, February 13, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, July 18, 2025 | ASSIGNED TO EXAMINER |
| Monday, July 21, 2025 | NON-FINAL ACTION WRITTEN |
| Monday, July 21, 2025 | NON-FINAL ACTION E-MAILED |
| Monday, July 21, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, July 21, 2025 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Monday, July 21, 2025 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
| Tuesday, October 7, 2025 | ATTORNEY REVIEW COMPLETED |
| Monday, October 20, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, October 20, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, October 20, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |